Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
On Tuesday, HCA Healthcare Inc. (NYSE:HCA) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the consensus of $17.05 billion.
HCA healthcare在週二發佈了二季度業績，營業收入爲174.9億美元，高於去年同期的158.6億美元，超過市場預期的170.5億美元。
The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the consensus of $5.36.
該醫院連鎖集團報告的調整後每股收益爲5.50美元，高於去年同期的4.29美元，超過市場預期的5.36美元。
"The company's results for the second quarter were positive and reflected strong demand for our services," said Sam Hazen, Chief Executive Officer of HCA Healthcare.
HCA healthcare的首席執行官Sam Hazen表示：公司第二季度的業績表現積極，反映了服務強勁的需求。
In the second quarter of 2024, same-facility admissions increased 5.8% year over year, while same-facility equivalent admissions increased 5.2%.
2024年第二季度，同單位設施收治人數同比增長5.8%，同單位等價收治人數同比增長5.2%。
Same-facility emergency room visits increased by 5.5%. Same-facility inpatient surgeries increased 2.6%, and same-facility outpatient surgeries declined 2.1%.
同一設施的急診就診人數增加了5.5%。手術室住院手術同比增長了2.6%，門診手術同比下降了2.1%。
Same facility revenue per equivalent admission increased by 4.4%
同單位收入等價收治人數的營收增長了4.4%。
For the second quarter of 2024, adjusted EBITDA totaled $3.55 billion, compared to $3.06 billion a year ago.
2024年第二季度，調整後EBITDA總額爲35.5億美元，而去年同期爲30.6億美元。
Guidance: HCA Healthcare revised its fiscal year 2024 revenue guidance to $69.75 billion-$71.75 billion compared to prior guidance of $67.75 billion-$70.25 billion and the consensus of $69.79 billion.
指導方針：HCA Healthcare將其2024財年營收指導範圍修正爲697.5億-717.5億美元，而先前的指導爲677.5億-702.5億美元，市場預期爲697.9億美元。
The company forecasts 2024 EPS guidance of $21.60-22.80, up from the prior guidance of $19.70-$21.20 and the consensus of $20.98.
該公司預測2024年每股收益指引爲21.60-22.80美元，高於先前的指導範圍19.70-21.20美元和市場預期20.98美元。
The company expects 2024 adjusted EBITDA of $12.85 billion-$13.55 billion versus the prior guidance of $13.75 billion-$14.25 billion.
該公司預計2024年調整後的EBITDA爲128.5億-135.5億美元，而先前的指導範圍爲137.5億-142.5億美元。
Reuters reported that some analysts anticipate U.S. hospitals will benefit from an aging population, while others believe a shift also drives the increased demand for ambulatory care centers that don't require overnight stays.
路透社報道稱，一些分析師預計美國醫院將受益於人口老齡化，而其他人則認爲，不需要夜盤交易的門診診所的增長也推動了對其增加需求。
Over the past year, demand for medical care has surged as Americans, particularly older adults, address non-urgent procedures delayed during the pandemic.
過去一年中，隨着美國民衆（特別是老年人）處理在大流行期間推遲的非緊急手術，對醫療保健的需求飆升。
According to a Reuters report citing Mizuho analyst, the largest for-profit hospital operator in the U.S. raised its forecast, meeting the high expectations for the quarter.
據彭博社報道，援引瑞銀分析師的話稱，美國最大的盈利性醫院運營商之一HCA Healthcare提高了其預測，達到了季度的高預期。
The stock of peers Universal Health Services Inc (NYSE:UHS) and Community Health Systems Inc (NYSE:CYH) also trade higher.
同行的醫療公司Universal Health Services Inc（NYSE：UHS）和Community Health Systems Inc（NYSE：CYH）的股票也有所上漲。
Price Action: HCA Healthcare stock is up 4.81% at $341.33 at last check on Tuesday.
價格表現：HCA Healthcare股票於週二的最新交易中上漲了4.81%，報341.33美元。
- EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder.
- Adial Pharmaceuticals獨家報道：AD04用於酒精性障礙的藥物代謝動力學研究進入第二隊。
Photo via Company
照片來自公司